CN · Field Sheet
FIELD SHEET — PINE BARK MFI-PINEBA-20261013-FS
Survey index / PINE BARK

Pine bark.

Pinus pinaster / Pinus maritima / Pinus radiata / Pinus sylvestris
Maritime pine bark extract; circulation and inflammatory coverage.
SEALED MFI-PINEBA-20261013-FS · RELEASED 2026-10-13
SHEET FINGERPRINTMFI-PINEBA-20261013-FS
286INCLUDED
2,168EXCLUDED
123DUPLICATE
32NON-TRANSFERABLE
0OUT OF CUTOFF
Survey totalsScroll ↓
2,609records surveyed
286studies
25claims graded
415observations
8,980graph nodes

Claim records

2 shown · bounded preview
RECORD PREVIEW · FIELD RECORD ×2BOUNDED — REAL RELEASED DATA
CLAIM · CLM-a653ad6476b912b6GRADE VERY_LOW
pine bark constituents — antioxidant
direction BENEFIT · dose 1 mg/kg; 10 mg/kg; 100 mg; 150 mg; 40 mg/kg; 480 mg · duration 10 days; 12 months; 14 days; 2 months; 30 day; 4 week; 4 weeks; 6 months; 6 weeks; 8 months; 8 weeks; 9 week
Grade basis — weakest-link ceilings
MODERATEdesign
LOWdirectness
LOWextraction
VERY_LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
32bound studies
Bound studies (4 shown of 32)
STU-0246d6fa44a93941
UNSPECIFIED · HUMAN · 2002 · RoB NOT_ASSESSABLE
2 endpoints
STU-18ae098f2bae1ebf
RCT · HUMAN · 2018 · 14 days · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-20e8f3b574aa86d0
UNSPECIFIED · HUMAN · 2018 · RoB NOT_ASSESSABLE
2 endpoints
STU-2bb42f3343079e15
UNSPECIFIED · HUMAN · 2022 · 8 months · RoB NOT_ASSESSABLE
2 endpoints
Quantitative observations
effect p < 0.05 · failed extraction
p_value p = 0.05 · validated
duration 14 days · failed extraction
Opposition screen
SCREEN · 42 candidates considered · 0 bound as opposing
SYNTHESIS SYN-ed6c5d750a460e — outcome QUALITATIVE_ONLY · BENEFIT ×32 · not_assessed_quantitatively · 32 members
PROVENANCE → epmc:12530550, epmc:PPR48048, epmc:30328688 · PKG 64ed41dfaf93204b…
CLAIM · CLM-50715798532cdd61GRADE VERY_LOW
pine bark constituents — inflammation
direction BENEFIT · dose 100 mg; 100 mg/kg; 150 mg; 200 mg; 50 mg · duration 10 days; 2 months; 4 week; 4 weeks; 5 day; 6 months; 8 weeks
Grade basis — weakest-link ceilings
HIGHdesign
LOWdirectness
LOWextraction
VERY_LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
23bound studies
Bound studies (4 shown of 23)
STU-20e8f3b574aa86d0
UNSPECIFIED · HUMAN · 2018 · RoB NOT_ASSESSABLE
2 endpoints
STU-2125b68c5b95c52f
IN_VITRO · IN_VITRO · 2018 · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-356afb2fbe20051e
ANIMAL · ANIMAL · 2009 · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-35d09bc9093f8688
UNSPECIFIED · HUMAN · 2010 · RoB NOT_ASSESSABLE
3 endpoints
Quantitative observations
n 14 · validated
effect p<0.05 · failed extraction
p_value p<0.05 · validated
Opposition screen
SCREEN · 29 candidates considered · 0 bound as opposing
SYNTHESIS SYN-ef45adca9a6869 — outcome QUALITATIVE_ONLY · BENEFIT ×23 · not_assessed_quantitatively · 23 members
PROVENANCE → epmc:30328688, epmc:28836883, epmc:20657531 · PKG 64ed41dfaf93204b…
Bounded preview — representative records only. The full release ships 25 claims and 415 observations.